Avoiding infliximab in the treatment of Crohn's disease in patients with multiple sclerosis.
Shardul A
SA
Nanavati
Gulchin A
GA
Ergun
Jim T
JT
Schwartz
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications* / Q000175:diagnosis; D018570:Risk Assessment
D000911:Antibodies, Monoclonal; D000069285:Infliximab